The protective role of uteroglobin through the modulation of tissue transglutaminase in the experimental crescentic glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 23, Issue 11, 2008, Pages 3437-3445

  Yang, Seung Hee ^a,b   Shin, Sung Joon ^c   Oh, Ji Eun ^d   Jin, Ji Zhe ^a   Chung, Nam Hyun ^b   Lim, Chun Soo ^a   Kim, Suhnggwon ^a   Kim, Yon Su ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Dongguk University College of Medicine   (South Korea)

^d Hallym University College of Medicine   (South Korea)

Author keywords

Experimental crescentic glomerulonephritis; Tissue transglutaminase; Uteroglobin

Indexed keywords

LIPOPOLYSACCHARIDE; MERCAPTAMINE; NITROGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA1; UREA; UTEROGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN CELL; KIDNEY SCAR; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RENAL PROTECTION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; HUMANS; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1; TRANSGLUTAMINASES; UTEROGLOBIN;

EID: 54149085961     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn268     Document Type: Article

References (27)

1. ESRD Registry Committee KSoN. Renal replacement therapy in Korea-insan memorial registry 2006. Korean J Nephrol 2007; 26: s459-s481
2. Tipping PG, Kitching AR. Glomerulonephritis, Th1 and Th2: what's new? Clin Exp Immunol 2005; 142: 207-215
3. Odobasic D, Kitching AR, Semple TJ et al. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis. J Am Soc Nephrol 2007; 18: 760-770
4. Wakayama H, Hasegawa Y, Kawabe T et al. Abolition of antiglomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficientmice. Eur J Immunol 2000; 30: 1182-1190
5. Lee DS, Yang SH, Kim HL et al. Recombinant uteroglobin prevents the experimental crescentic glomerulonephritis. Kidney Int 2004; 66: 1061-1067
6. Tipping PG, Huang XR, Qi M et al. Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells. Am J Pathol 1998; 152: 1541-1548
7. Ka SM, Huang XR, Lan HY et al. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J Am Soc Nephrol 2007; 18: 1777-1788
8. Lan HY, Mu W, Tomita N et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 2003; 14: 1535-1548
9. Hou CC, Wang W, Huang XR et al. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am J Pathol 2005; 166: 761-771
10. Zhou A, Ueno H, Shimomura M et al. Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis. Kidney Int 2003; 64: 92-101
11. Song CY, Kim BC, Hong HK et al. TGF-beta type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis. Kidney Int 2007; 71: 882-888
12. Basile DP. The transforming growth factor beta system in kidney disease and repair: recent progress and future directions. Curr Opin Nephrol Hypertens 1999; 8: 21-30
13. Douthwaite JA, Johnson TS, Haylor JL et al. Effects of transforming growth factor-beta1 on renal extracellular matrix components and their regulating proteins. J Am Soc Nephrol 1999; 10: 2109-2119
14. Johnson TS, El-Koraie AF, Skill NJ et al. Tissue transglutaminase and the progression of human renal scarring. J Am Soc Nephrol 2003; 14: 2052-2062
15. Miele L, Cordella-Miele E, Mantile G et al. Uteroglobin and uteroglobin-like proteins: the uteroglobin family of proteins. J Endocrinol Invest 1994; 17: 679-692
16. Mukherjee AB, Kundu GC, Mantile-Selvaggi G et al. Uteroglobin: a novel cytokine? Cell Mol Life Sci 1999; 55: 771-787
17. Dierynck I, Bernard A, Roels H et al. Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC16. Am J Respir Cell Mol Biol 1995; 12: 205-210
18. Manjunath R, Chung SI, Mukherjee AB. Crosslinking of uteroglobin by transglutaminase. Biochem Biophys Res Commun 1984; 121: 400-407
19. Gadola L, Noboa O, Marquez MN et al. Calcium citrate ameliorates the progression of chronic renal injury. Kidney Int 2004; 65: 1224-1230
20. Tang WW, Feng L, Loskutoff DJ et al. Glomerular extracellular matrix accumulation in experimental anti-GBM Ab glomerulonephritis. Nephron 2000; 84: 40-48
21. Chihara Y, Ono H, Ishimitsu T et al. Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy. Clin Nephrol 2006; 65: 385-392
22. Gagliardini E, Benigni A. Therapeutic potential of TGF-beta inhibition in chronic renal failure. Expert Opin Biol Ther 2007; 7: 293-304
23. Kim JH, Ha IS, Hwang CI et al. Gene expression profiling of anti-GBM glomerulonephritis model: the role of NF-kappa B in immune complex kidney disease. Kidney Int 2004; 66: 1826-1837
24. Ikee R, Kobayashi S, Hemmi N et al. Involvement of transglutaminase-2 in pathological changes in renal disease. Nephron Clin Pract 2007; 105: c139-c146
25. Priglinger SG, Alge CS, Neubauer AS et al. TGF-beta2-induced cell surface tissue transglutaminase increases adhesion and migration of RPE cells on fibronectin through the gelatin-binding domain. Invest Ophthalmol Vis Sci 2004; 45: 955-963
26. Moreno JJ. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase. Int Immunopharmacol 2006; 6: 300-303
27. Antonyak MA, Jansen JM, Miller AM et al. Two isoforms of tissue transglutaminase mediate opposing cellular fates. Proc Natl Acad Sci USA 2006; 103: 18609-18614